4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-23-039080
Director acquired 16,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Molineaux Christopher P. · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-06-20 | Exercise or conversion : show line 1 in the form | +16,500 | $1.41 | $23,265 | 48,503 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-06-20 | Exercise or conversion : show line 2 in the form Stock Option (right to buy) | −16,500 | 0 | D |
Loading xslF345X04/doc4.xml…